Amalgamated Bank Relay Therapeutics, Inc. Call Options Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RLAY
# of Institutions
209Shares Held
163MCall Options Held
694KPut Options Held
36.1K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$176 Million1.1% of portfolio
-
Commodore Capital LP New York, NY17MShares$107 Million5.66% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct14.8MShares$92.9 Million0.15% of portfolio
-
Casdin Capital, LLC New York, NY11.3MShares$71.3 Million8.07% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$66.3 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $756M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...